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Abstract
Traumatic brain injury affects many people each year, resulting in a serious burden 
of devastating health consequences. Motor-vehicle and work-related accidents, falls, 
assaults, as well as sport activities are the most common causes of traumatic brain 
injuries. Consequently, they may lead to permanent or transient pituitary insufficiency 
that causes adverse changes in body composition, worrisome metabolic function, reduced 
bone density, and a significant decrease in one’s quality of life. The prevalence of post-
traumatic hypopituitarism is difficult to determine, and the exact mechanisms lying behind 
it remain unclear. Several probable hypotheses have been suggested. The diagnosis of 
pituitary dysfunction is very challenging both due to the common occurrence of brain 
injuries, the subtle character of clinical manifestations, the variable course of the disease, 
as well as the lack of proper diagnostic algorithms. Insufficiency of somatotropic axis is 
the most common abnormality, followed by presence of hypogonadism, hypothyroidism, 
hypocortisolism, and diabetes insipidus. The purpose of this review is to summarize 
the current state of knowledge about post-traumatic hypopituitarism. Moreover, based 
on available data and on our own clinical experience, we suggest an algorithm for the 
evaluation of post-traumatic hypopituitarism. In addition, well-designed studies are 
needed to further investigate the pathophysiology, epidemiology, and timing of pituitary 
dysfunction after a traumatic brain injury with the purpose of establishing appropriate 
standards of care.
Introduction and epidemiology
Traumatic brain injury (TBI) is commonly defined as 
any brain pathology caused by an external force. TBI, 
sometimes referred to as a ‘silent epidemic’, affects about 
69 million people each year, occurs commonly in young 
adults, and causes a serious burden of devastating health 
consequences (1, 2). The Glasgow Coma Scale (GCS) is 
used to divide TBI into mild (concussion, 13–15 points), 
moderate (9–12 points), and severe (3–8 points). Another 
classification of TBI distinguishes between closed (blunt) 
and open (penetrating) traumas (3); the latter are always 
severe. It is difficult to determine the actual prevalence and 
incidence of TBI. Numerous patients with mild injuries 
neglect further diagnostics or who are treated at primary 
healthcare centers do not count in hospital statistics. 
A study based on data from 13 European countries 
estimated that the incidence of TBI incidence is 235 per 
100,000 per year (4) and another one reported 506 TBI 
cases per 100,000 in the USA (5). The recent systematic 
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review by Nguyen et al. concluded that the pooled annual 
incidence rate of TBI is 349 per 100,000 person-years. Mild, 
moderate, and severe TBI pooled annual incidence were 
224, 23, and 13 per 100,000, respectively (6). In Europe, 
annual mortality rate associated with TBI was estimated to 
be 15 per 100,000 (4). Head traumas are twice as common 
in men as in women (7). Falls, motor-vehicle and work-
related accidents, assaults, as well as sport activities are the 
most typical causes of brain injuries. Pituitary dysfunction 
resulting as a consequence of brain injury is not a new 
phenomenon – the first article illustrating the matter was 
published in 1918 (8). Nowadays, the topic is gaining 
more and more attention due to new reports of pituitary 
insufficiency caused by relatively mild, repetitive brain 
traumas. The incidence of post-traumatic hypopituitarism 
(PTHP) is likely underestimated. Based on the review of 
literature published between May 2000 and October 
2018, Benvenga defined that PTHP accounts for 7.2% of 
the total cases of hypopituitarism (9). The prevalence of 
PTHP among patients with a history of TBI is estimated 
to be 15–68% (10, 11, 12). Symptoms may present at any 
time after the inflicting trauma (5). The severity of brain 
injuries corresponds to the development of the observed 
deficiencies: PTHP was diagnosed in 16.8%, 10.9%, and 
35.5% of patients with mild, moderate, and severe TBI, 
respectively (10, 13). Insufficiency of somatotropic axis 
is the most common abnormality, followed by presence 
of hypogonadism, hypothyroidism, hypocortisolism, 
and diabetes insipidus (14, 15, 16). Pituitary dysfunction 
after a traumatic brain injury is usually transient and 
may resolve or regain its functional abilities within 1 to 
3 years; however, it can also present itself clinically or 
develop many years after the initial TBI (17).
Pathogenesis
The exact mechanism of post-traumatic hypopituitarism 
remains unclear. Several probable hypotheses have 
been suggested. The unique location and the intricate 
vascularization of the pituitary gland plays a key role in 
the pathogenesis of post-traumatic hypopituitarism (18, 
19). Shearing forces during brain injuries may damage 
the vessels supplying the pituitary gland and lead to the 
necrosis of the pituitary lobes. Similar effect results from 
compression due to the increased intracranial pressure 
(20, 21, 22). Stalk amputation or stalk displacement 
caused by mass effect may influence the blood supply to 
the pituitary lobes (21). Moreover, general hypovolemia 
provides alternative explanations to pituitary gland 
ischemia. Sheehan syndrome is a well-known consequence 
of traumatic labor involving significant blood loss (23). 
Additionally, pituitary apoplexy has been reported in 
a previously healthy adolescent patient after serious 
thoracic trauma requiring surgery due to the dissection of 
descending aorta (24). Furthermore, thyroidectomy (25), 
CABG (26), or lung resection (27) has been shown to be 
probable causes that lead to hypopituitarism in patients 
with preexisting pituitary enlargement or adenoma.
The impaired vascular supply hypothesis explains the 
observed hormonal abnormalities seen in post-traumatic 
hypopituitarism. It correlates well with the distribution 
of somatotrophs and gonadotrophs which are located 
in the lateral part of the anterior pituitary lobe and pars 
tuberalis, respectively – areas susceptible to ischemia due 
to portal vessels blood supply (19). The central portion 
of the gland comprising cortico- and thyrotrophs is 
supplied mainly by short hypophyseal portal vessels 
and, thanks to that, remains less susceptible to ischemic 
traumas (28, 29). Benvenga et al. confirmed MRI changes 
of the hypothalamus/pituitary area in 93% patients who 
suffered from post-traumatic pituitary dysfunction (30). 
Fatal TBI cases were associated with pituitary infarction 
in up to 43% of autopsies (20). The hypothalamus is not 
typically injured in brain trauma; however, increased 
intracranial pressure may play a role in the apoptosis 
of cells in the hippocampus, hypothalamus, and the 
pituitary gland (31).
The impact forces generated by traumatic brain injury 
may directly harm the pituitary gland, especially its stalk, 
and result in abnormal hormone production (32, 33, 34). 
Head traumas may result in axonal brain injury – subtle 
changes to the nerve tissue, detectable only with the use 
of the newest visualizing techniques (35). Experimental 
studies in animals suggest two additional alternative 
mechanisms of PTHP. The first one describes inflammation 
and astrocytosis in hypothalamus-pituitary area (36), 
while the second focuses on tanycytes, the barrier cells 
of the third ventricle, whose inappropriate junctions may 
impact the hypothalamus function (37).
In recent years, more attention has been put to the 
link between PTHP and autoimmunity. TBI may induce 
an inflammation in the nervous system (38, 39) as 
well as an increase in the permeability of blood-brain 
barrier, resulting in the excessive exposure of pituitary 
and hypothalamic antigens (40). The presence of 
autoantibodies against pituitary (APA) and hypothalamus 
(AHA) was reported in patients with post-traumatic 
hypopituitarism even 5 years after the initial diagnosis 
(41). Tanriverdi et  al. found APA in 44.8% of patients 
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3 years after they sustained their brain injury. No antibodies 
were detected in the control group whose patients were 
matched by age and gender (42). Higher values of APA in 
post TBI patients were associated with a more frequent 
development of pituitary insufficiency, while negative 
antibody titers were associated with a recovery of the 
pituitary function in a 5-year prospective study (39, 43). 
Antibodies against pituitary gland and hypothalamus 
(in 22.9% and 21.3% of cases, respectively) were found 
in a study of 61 professional boxers. Their presence was 
associated with a higher incidence of hypopituitarism 
(46.2% vs 10.4%) (44). Persistent hypopituitarism in 
Sheehan’s syndrome may have autoimmune background 
as well, since APA and AHA have been detected in women 
many years after their initial diagnosis (45). Further 
research is needed to define the exact significance of 
autoimmune reactions in post-traumatic insufficiency of 
the pituitary gland. The presence of specific antibodies 
involved in the development and preservation of 
pituitary dysfunction can potentially help identify high-
risk patients and will allow the development of proper 
diagnostic and treatment algorithms (5).
Interestingly, a reduced risk of PTHP was described 
in patients with apolipoprotein E3 (APO E3) genotype. 
APO E3 is a protective protein with confirmed neuronal 
anti-inflammatory actions (42). These findings suggest 
that complex pathophysiology of PTHP may also have a 
genetic component. In addition, apolipoprotein E4 was 
proved to have a neuroprotective effect in patients with a 
history of concussion (46, 47).
Recent research reports that pituitary deficiency after 
TBI may be also related to an altered miRNA expression 
profile. Taheri et al. found that miR-126-3p and miR-3610 
were detected in the serum of patients who developed 
hypopituitarism on the 1st, 7th, and 28th days and in 
the 5th year following TBI. Further studies on examining 
the relationship between various miRNA and pituitary 
deficiency can help determine the role of specific genes 
controlled by miRNA. Therefore, miRNA may be used as 
potential indicators for the early diagnosis of patients 
who are at a higher risk of developing pituitary deficiency 
after TBI (48).
Sport-induced hypopituitarism
Sport-induced hypopituitarism (SIHP) is a relatively 
new endocrine problem. Little is known about the exact 
incidence of SIHP due to the difficult recognition of the 
cases. Specifically, contact sports, as well as equestrian 
and winter sports, and any sports-related fall or injury, are 
the most common activities that lead to brain injuries. 
This suggests that mild repetitive brain injuries sustained 
throughout an athlete’s career may accumulate to the 
magnitude of a severe trauma and lead to pituitary gland 
dysfunction (49, 50, 51, 52). Worldwide, there is a growing 
popularity of boxing and kickboxing, both of which are 
known to cause repetitive head trauma and thus pituitary 
insufficiency (53).
In the study of 61 boxers, Tanriverdi found growth 
hormone deficiency in 15% of them (which correlated 
with a decreased pituitary volume) and also ACTH 
deficiency in 8% of the participants (42). The same author 
reported decreased IGF-1 levels in amateur kickboxers; 
22% and 9% of them were diagnosed with GH and ACTH 
deficiency, respectively (54). In another study, Kelestimur 
et al. described a negative correlation between stimulated 
GH peak and both the number of fights and the time 
spent boxing (53).
Football players may be affected by SIHP as well. 
Hormonal deficiency has been reported in 23.5% of 
evaluated patients (14.7% presented with growth hormone 
deficiency, 4.4% presented with hypogonadism, and 4.4% 
presented with abnormalities in both) (55). The literature 
also describes anecdotal cases of SIHP in swimmers and 
soccer players (56, 57).
Blast-related hypopituitarism
The relatively high prevalence of chronic hypopituitarism 
among military veterans attracted more attention to blast 
injuries as a possible culprit. Wilkinson et al. evaluated 26 
veterans with a history of blast exposure, among which 11 
(42%) presented hormonal abnormalities – somatotropic 
and gonadal axes being most affected (58). The potential 
mechanism is likely associated with the blastwave and the 
secondary injuries that may elicit cell destruction, vascular 
changes, and diffuse axonal injuries in the pituitary gland 
(59, 60). Growth hormone deficiency was confirmed 
by the glucagon stimulation test in 25% of 20 soldiers 
who suffered mild TBI (85% of them as a result of blast 
injury) (61). In another study, Undurti et  al. compared 
39 male soldiers with a history of blast related TBI and 
20 soldiers who had not experienced explosion lesions 
(both groups were deployed under similar conditions). 
Hormonal abnormalities were detected in 31% and 15% 
of participants, respectively, with growth hormone deficit 
being the most common abnormality (62). Baxter et  al. 
documented a significantly higher ratio (32%) of anterior 
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pituitary dysfunction in patients with a history of direct 
blast exposure relative to patients with non-blast-TBI 
(2,6%). The study was extended to include an assessment 
of the hypothalamic-pituitary area on MRI studies, in 
which brain scans did not reveal any pathological changes 
in post-blast patients (63).
In addition to the previously mentioned changes, 
blast related hypopituitarism is also associated with a 
decreased quality of life, a higher rate of depression, and 
post-traumatic stress disorders (61, 62).
Children and adolescents
Posttraumatic hypopituitarism in children is uncommon. 
Again, it is difficult to establish its prevalence. Personier 
et al. estimated the incidence of PTHP in children at 8% 
(64). Two studies, one including 198 subjects younger 
than 2 years of age and a second study with 37 children 
under 6 years of age did not report any evidence of 
pituitary dysfunction (65, 66). In older children, growth 
hormone deficiency was present in about 34% of patients 
1 year after an injury. Regular auxological assessments are 
important in the early detection of the condition (67) as 
well as any records of adverse changes in body habitus, as 
15% of children with TBI were reported to be overweight 
during their final evaluation in a study of Jourdan et al. 
(68). In a systematic review of literature, Soliman et  al. 
estimated that the rates of ACTH, LH/FSH, GH, and TSH 
deficiencies in children with TBI were 2–43%, 6–16%, 
6–48%, and 2–33%, respectively (69). Lastly, repetitive TBI 
in young patients may also have a significant influence 
on subsequent reproductive complications and physical 
growth (70, 71, 72).
Presentation
Traumatic brain injury is a compound disease process 
beginning at the moment of trauma and evolving with time 
(73). The development of post-traumatic hypopituitarism 
can vary and may overlap with nonspecific symptoms 
resulting from the injury. Thus, the diagnosis is often 
challenging. The delay in the disease recognition and 
the severity of the hormonal deficits may determine the 
clinical presentation (74). The symptoms resemble other 
forms of hypopituitarism.
PTHP results in a higher morbidity and mortality 
(75). The survivors face decreased quality of life, 
adverse changes in their body composition, abnormal 
metabolic tests, and reduced bone density (76, 77). 
Recent studies attribute more attention to cognitive 
and affective impairment among the patients, not only 
due to the brain injury itself but also due to PTHP (75). 
Neuropsychiatric symptoms range from mild to severe and 
may significantly affect patients’ function in the society 
(74). Due to the fact that each anterior pituitary lobe axis 
is involved, hormone replacement therapy may improve 
the recovery of cognitive functions (78, 79, 80). Thyroid 
hormones were found to play a role in neurogenesis in 
rats (81). Testosterone substitution may improve memory 
in patients with hypogonadism (82) and protect from an 
increased risk of Alzheimer’s disease (83). The influence 
of estrogen therapy on cognitive function is not fully 
understood (84). Kelly et al. confirmed that patients with 
post-traumatic GH deficiency (GHD) have more severe 
cognitive impairment than those with normal values of 
GH (85). Several studies reported more frequent deficits 
in memory and attention, worse reaction-times, as well 
as emotional problems in subjects with GHD (86, 87). 
In contrary, Pavlovic et  al. did not detect significant 
differences between post-traumatic patients with and 
without GHD (87). Lower IGF-1 levels were associated with 
worse visual memory (88) and increased risk of Alzheimer’s 
disease (89). Due to the similarity of symptoms, there is a 
discussion about the contribution of post-TBI hormonal 
abnormalities to the clinical presentation of PTSD (62). 
Similar psychiatric alterations were found in TBI patients 
with/without PTHP, but therapy with growth hormone 
improved mental function (88, 89, 90).
Another important abnormality in patients with PTHP 
is related to changes in metabolic profile. Increased BMI 
and higher values of total cholesterol as well as its LDL 
fraction were reported in subjects with PTHP (75). Patients 
with anterior pituitary lobe hormonal deficits post TBI 
were reported to have increased blood glucose, insulin 
resistance, dyslipidemia, higher waist circumference, and 
increased abdominal fat and leptin values (76, 91). The 
probable mechanisms beyond weight gain in patients 
with PTHP include altered function of hypothalamic 
nuclei, which control energy homeostasis, changes in 
circadian rhythms, mood alterations, and bodily response 
to medications (73).
Acute stage
The first 2 weeks following trauma are considered as an 
acute-phase. Hannon et  al. defined the prevalence of 
pituitary dysfunction in 78% of patients with history of 
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traumatic brain injury (92). Possible physiological changes, 
adaptive changes related to their critical condition, or 
difficulties in performing dynamic testing in these patients 
make the assessment of hormonal profile challenging. 
Deficits in gonadotropin and growth hormone are the 
most common changes among patients in the acute phase 
of TBI. However, it is absolutely crucial to detect any signs 
of adrenal insufficiency. No risk factors for ACTH deficits 
have been identified so far. The condition was found in 
78% of hospitalized patients within 10 days of moderate 
and severe TBI (based on cortisol level lower than 11 µg/dL) 
(92). In another study, Bensalah et  al. evaluated 200 
patients during the first week after they sustained a TBI. 
He concluded that 2.8%, 21%, and 37% of the patients 
presented with a cortisol level below 3, 10, and 15 µg/dL, 
respectively (93). Patients with secondary hypocortisolism 
are known to require a higher level of vasopressors and 
often suffer from a higher mortality rate (92, 94). Since 
hypoadrenalism is potentially life-threatening, hormone 
replacement therapy should be introduced immediately. 
It should be noted that cortisolemia may be affected by 
drugs (i.e. etomidate, propofol) that were administered 
in the intensive care units (94). Various prolactin levels 
were reported in patients with PTHP – hyperprolactinemia 
may be associated with a reduced inhibiting action of 
dopamine, often caused by stalk compression and/or 
physiological reaction to stress (95). Other changes 
such as decreased thyroxin and antidiuretic hormones 
may also be detected (96). These changes are usually 
transient and resolve within 3–12 months (97, 98, 99). 
Thus, a number of authors cast doubt on the benefits 
of acute-phase hormonal therapy (10, 100). Impaired 
vasopressin secretion (central diabetes insipidus – CDI as 
well as syndrome of inappropriate antidiuretic hormone 
hypersecretion – SIADH) in patients with TBI are usually 
transient, yet sometimes the recovery period may last 
months (101). Central Diabetes Insipidus occurs in 
16–28% of patients with TBI (30, 101) and correlates 
with the severity of the trauma, the resulting cerebral 
edema, and the mortality rate (82, 102). Early detection 
of CDI or SIADH is essential in patients presenting with 
severed neurological function, where hydro-electrolytic 
imbalance may be life-threatening (103).
Chronic stage
Due to the challenges in evaluating pituitary function 
during the acute phase post TBI as well as the multitude of 
dynamic changes that follow the injury, patients should 
be reassessed in follow-up studies (5). The chronic-phase of 
the PTHP is said to begin 3 months after the initial trauma. 
Data about the prevalence of the condition are unclear. 
Between 5.4 to 76.4% of patients present with long-term 
pituitary hormone abnormalities (104). The wide range 
in presentation is likely due to the significant differences 
in the diagnostic criteria. It should be underlined that 
basic hormonal values, without dynamic tests, may lead 
to inappropriate description of the pituitary function. 
Similar to the acute phase, growth hormone deficiency 
and hypogonadism are the two most common anomalies 
seen in the chronic phase. Long-term ACTH and TSH 
deficits are relatively rare (less than 10% of cases) (31). 
These results are consistent with the Taniverdi study, 
where GH, ACTH and LH/FSH deficits were found in 28%, 
4%, and 4%, respectively, 5 years post initial trauma (43). 
Central diabetes insipidus is persistent in 7% of patients 
in long-term observational studies (101).
Diagnostic approach
High occurrence of traumatic brain injuries makes 
routine endocrinological screening controversial. British 
Neurotrauma Group guidelines recommend performing 
a hormonal assessment in patients hospitalized for more 
than 48 h following a TBI (31). Patients with a mild 
TBI should be screened if they present with symptoms 
of hypopituitarism (105). According to the suggested 
algorithm, first post-acute phase evaluation should be 
performed between 3 and 6 months after the injury (31, 
100, 106). Thyroid and gonadal axes assessment includes 
measurements of TSH, fT4, gonadotropins, estrogens in 
women, and testosterone in men. Morning cortisol level 
greater than 18 ug/dL indicates proper ACTH/adrenal 
function, while a concentration lower than 3 µg/dL is 
a marker of hypoadrenalism (31, 107). Cortisol values 
between 3 and 18 µg/dL require further investigation 
through stimulating tests, of which short synacthen test 
is commonly used (108). Somatotropic axis evaluation 
should be postponed until 1 year after the injury, with the 
exception of children, who may require earlier assessment. 
In patients with multi-hormonal abnormalities, low IGF-1 
levels may suggest growth hormone deficiency (GHD) 
(105). Various tests can confirm GHD with a high level 
of confidence (109, 110). The possibility of persistent CDI 
should also be taken into consideration (106).
There are valuable algorithms that help predict clinical 
outcome of severe traumatic brain injury. The IMPACT 
calculator assesses age, the motor score component 




https://ec.bioscientifica.com © 2020 The authors
Published by Bioscientifica Ltd









of GCS, and the pupillary reaction. The expanded 
version, including in addition levels of glial fibrillary 
acidic protein, ubiquitin C-terminal hydrolase-L1, 
and αII-spectrin breakdown products measured in the 
serum and the cerebrospinal fluid of patients with TBI, 
correlates with a 6-month mortality rate (111). This 
information may be an invaluable prognostic model; 
however, it does not refer specifically to the posttraumatic 
pituitary function. Moreover, the study of the previously 
mentioned biomarkers is not widely available in 
clinical practice.
Based on the current available literature and on our 
own experience, we suggest a novel algorithm for the 
evaluation of post-traumatic hypopituitarism (Fig. 1).
Imaging
Radiological presentation of patients with a history of 
traumatic brain injury varies significantly. Certain changes, 
especially related to mild TBI, may be undetectable 
using routine imaging (35). Although CT is usually 
more easily available in acute conditions and provides 
better visualization of skull fractures, MRI is far superior 
for assessment of intracranial hematomas, contusion, 
and shearing injuries, with an estimated sensitivity of 
96.4% (compared to a sensitivity of 63.4% for CT studies) 
(112, 113). Kelly et  al. documented that diffuse brain 
swelling may be a predictive factor for post-traumatic 
pituitary dysfunction (114). The association between 
Figure 1
Proposed algorithm for diagnosis of pituitary 
function after traumatic brain injury (data from 
Glynn & Agha (105), Czeiter et al. (111), 
Fernandez-Rodriguez et al. (126), and Herrmann 
et al. (127)). TBI, traumatic brain injury; GCS, 
Glasgow coma scale; TSH, thyroid-stimulating 
hormone; GH, growth hormone; FSH, follicle 
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basal skull fractures or diffuse axonal injury and PTHP was 
identified by Schneider et al. (115). In addition, patients 
with PTHP show more chronic abnormalities in magnetic 
resonance (16, 116). Relative to patients who suffered 
a TBI but did not present with pituitary dysfunction, 
microstructural damages of the pituitary gland tissues 
in patients with PTHP present as decreased water 
diffusion on MRI studies (117). Specifically, a reduction 
in the pituitary size may result from the necrosis and/or 
intracranial hypertension (16, 117). Decreased pituitary 
volume was also seen in a professional boxer who suffered 
from GHD when compared to a professional boxer whose 
GH were within the normal range (118). MRI images 
in further studies may reveal atypical enhancement of 
the pituitary gland, an empty sella, and/or abnormal 
pituitary lobe signal (119).
Treatment
The cornerstone of treatment of patients with post-
traumatic hypopituitarism is hormonal replacement. 
The general principles of the treatment resemble those 
used in other forms of pituitary dysfunction (120). 
Deficits in GH, TSH, and LH/FSH are usually transient, 
and there is no data in the current literature regarding 
the benefits of hormonal replacement in the acute 
phase (10, 101). In contrast, decreased ACTH/cortisol 
level should be detected as soon as possible, to ensure 
appropriate administration of hydrocortisone. Patients 
who present with ACTH deficiency symptoms should first 
be stabilized. Next, they should be re-tested, to determine 
whether they have a persistent hypocortisolism (121, 
122). Proper hormonal replacement has a potential to 
reverse the symptoms and to reduce the risk associated 
with hypocortisolism (10). Growth hormone substitution 
in the chronic phase improves cognitive function, body 
composition, and quality of life (91, 123). In long term 
studies, even patients without detectable abnormalities 
in their hormonal profile should be cognizant of possible 
worrisome signs and symptoms of hypopituitarism (14).
Prognosis
A systematic review by Tanriverdi et al. concluded that the 
predictive factors of long-term PTHP include: the presence 
of intracranial hypertension, the initial severity of brain 
trauma on the CT scan, the magnitude of diffuse axonal 
injury, the age of the patient, duration of hospitalization 
in an intensive care unit, the presence of rapidly changing 
hormone values, any basal skull fractures, and the 
presence of anti-pituitary or anti-hypothalamic antibodies 
(121). Persistent GH deficiency is also a negative predictor 
of one's recovery from TBI (10, 34). In another study, 
Hannon et  al. emphasized the occurrence of acute-
phase cortisol deficits as a predictor of mortality and 
chronic hypopituitarism (93). In the majority of cases, 
PTHP is transient – probably due to the fact that some 
pathological changes (i.e. hypoperfusion, intracranial 
hypertension, and edema) have a reversible character. 
The possible regeneration of hypophyseal vascularization 
should be taken into consideration as well (21). About 
55% of patients with PTHP recover within 3 months, and 
74–85% of patients recover within 1 year (29). Klose et al. 
reported a similar rate of improvement, documenting 
76% of patients affected by early pituitary dysfunction 
and only 11% 1 year after their TBI (124). The recovery of 
LH/FSH function was seen in most cases, followed by GH 
and ACTH (125). In contrast, Tanriverdi et al. reported that 
50% of 52 patients were diagnosed with new hormonal 
abnormalities a year after their TBI. These subjects were 
re-tested 5 years later and 24% of them presented with 
chronic hypopituitarism (98). However, the prognostic 
markers and the underlying recovery mechanism from 
a hypopituitarism state, either immediately after TBI 
or after a certain period of time, have not yet been 
determined. As mentioned earlier, glial fibrillary acidic 
protein, ubiquitin C-terminal hydrolase-L1, and αII-
spectrin breakdown product (SBDP145) are intensively 
investigated as potential elements of algorithms used for 
outcome prediction in patients after TBI (111).
Further research on the identification of specific 
antibodies, MiRNAs, neuro anti-inflammatory proteins, 
and other markers should be carried on, with the ultimate 
goal of developing indicators for the early diagnosis of 
patients who may potentially recover or develop pituitary 
deficiency after sustaining a TBI (42, 46, 48).
Conclusions
Traumatic brain injury management is a significant 
challenge for the healthcare systems in many countries. 
Lack of proper algorithms leads to the overlooking of 
post-traumatic hypopituitarism, which may have a 
great impact on patients’ health status and their quality 
of life. Specific screening methods should be created to 
identify patients who sustained traumatic brain injuries 
and who require further observation and/or treatment. 
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Further research is needed to explain the exact 
mechanisms responsible for pituitary dysfunction 
resulting from traumatic brain injury. Ultimately, these 
studies will help healthcare workers prevent PTHP and 
prepare them to provide optimal treatment to patients 
with these complications.
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